Home / Market Reports / Pharma & Healthcare
/ Global GMP Cell Banking Market Growth (Status and Outlook) 2024-2030
Global GMP Cell Banking Market Growth (Status and Outlook) 2024-2030
Product Code:816607
Published Date: Dec 24,2024
Pages: 111
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
Provide comprehensive and accurate analysis and reports according to your exact requirements
The global GMP Cell Banking market size is predicted to grow from US$ 700 million in 2024 to US$ 1435 million in 2030; it is expected to grow at a CAGR of 12.7% from 2024 to 2030.
Cell banking systems are set up to assure that a uniform population of cells is preserved, their integrity is maintained, and a sufficient supply of material is accessible for the life of the product. Biosafety testing is performed on cell lines at multiple passages. A cell bank comprises of a storage facility for cells extracted from different body fluids and organ tissue so that they can be used in the future. Stored cells contain detailed characterization of the cell line thereby decreasing chances of cross contamination. And GMP cell banking services consists of outsourcing gathering, storing, characterization, and testing facilities of cell lines, tissues, and cells. GMP basically stands for “Good Manufacturing Practice.”
The GMP Cell Banking market is primarily driven by the increasing demand for cell-based therapies, gene therapies, and biopharmaceuticals. As the global healthcare industry shifts towards personalized medicine and regenerative treatments, there is a growing need for high-quality, standardized cell banks to support the development of these advanced therapies. The rising prevalence of chronic diseases, genetic disorders, and the need for novel treatments are pushing the demand for safe, reliable, and scalable cell sources. Additionally, regulatory authorities are emphasizing the need for strict quality control in cell therapy products, further driving the need for GMP-compliant cell banking services to ensure product safety and consistency.
However, the market faces several challenges, particularly related to the high costs and complexity of establishing and maintaining GMP-compliant cell banks. The stringent regulatory requirements for quality control, facility standards, and documentation can result in significant operational expenses. Furthermore, the long-term storage of cells, as well as the risk of contamination or genetic instability, requires advanced infrastructure and specialized expertise, which can be resource-intensive. These factors, along with the limited availability of suitable cell sources, pose challenges for small and medium-sized enterprises entering the GMP Cell Banking market, potentially limiting market growth in certain regions.
Global key players of GMP cell banking include Charles River, Thermo Fisher, Lonza, Wuxi Apptec, etc. Global top five manufacturers hold a share over 55%. In terms of product, mammalian cell is the largest segment, with a share over 63%. And in terms of application, the largest application is biopharmaceutical companies, with a share over 75%.
LPI (LP Information)' newest research report, the “GMP Cell Banking Industry Forecast” looks at past sales and reviews total world GMP Cell Banking sales in 2023, providing a comprehensive analysis by region and market sector of projected GMP Cell Banking sales for 2024 through 2030. With GMP Cell Banking sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GMP Cell Banking industry.
This Insight Report provides a comprehensive analysis of the global GMP Cell Banking landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on GMP Cell Banking portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GMP Cell Banking market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GMP Cell Banking and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GMP Cell Banking.
This report presents a comprehensive overview, market shares, and growth opportunities of GMP Cell Banking market by product type, application, key players and key regions and countries.
Segmentation by Type:
Mammalian Cell
Microbial Cell
Insect Cell
Others
Segmentation by Application:
Biopharmaceutical Companies
Contract Manufacturing Organizations
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River
Thermo Fisher
Lonza
Wuxi Apptec
Eurofins Scientific
Merck KGaA
SGS Life Sciences
Sartorius
Catalent
Goodwin Biotechnology
Texcell
Precision for Medicine
Kryosphere
ProBi